The 6th Annual Symposium of UPMC, entitled “The Role of Stereotactic Radiotherapy in Multidisciplinary Oncological Outpatient Clinics” will take place on December 14-15, 2018 in the premises of the Auditorium Via Veneto (Via Veneto 89, Rome). The event is free and accredited on Agenas for the provision of 10 CME credits.
The goal of the 2018 UPMC Symposium is to compare the experiences of different Italian centers, highlighting common therapeutic strategies for treatment of the reviewed oncology diseases. Stereotactic Radiation Therapy (SRT) has modified the preexisting guidelines, times, and therapeutic associations. Thanks to its low toxicity and shorter time of treatment, SRT is included in the multidisciplinary therapeutic process, and associated with other surgical treatments and traditional (chemotherapy) and innovative (target therapy and immunotherapy) therapies.
The Symposium aims to bring together the different professionals involved in the treatment of oncology patients. Radiation oncologists, oncologists, surgeons and medical physicists will discuss treatment hypotesis, the decision tree implemented in their respective oncology outpatients clinics to treat neoplastic lesions in four body disctricts (brain, thorax, abdomen, and pelvis). Thanks to UPMC’s international stature and vast clinical experience, this event will represent a great opportunity to disseminate scientific knowledge on important techniques used to treat oncology patients across Europe and worldwide.
The Symposium is open to 100 health care professionals with the following roles and specializations:
Directions to UPMC San Pietro FBF.
The UPMC San Pietro FBF Advanced Radiotherapy Center offers innovative radiotherapy treatments and stereotactic radiosurgery with advanced protocols of care for patients with oncology diseases.
The Italian division of the University of Pittsburgh Medical Center with facilities in Rome (UPMC San Pietro FBF, oncology radiotherapy and Salvator Mundi International Hospital UPMC |UPMC), Palermo (ISMETT IRCCS, organ transplants and highly specialized therapies and Ri.MED Foundation, research).
UPMC is an integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, U.S.A. With its high clinical, management, research and training skills, UPMC is one of the leading health systems in the United States. UPMC Hillman Cancer Center UPMC's oncology network offering the latest advances in cancer prevention, detection, diagnosis, and treatment.